ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,702,701, issued on Aug. 11, was assigned to Canem Holdings LLC (Franklin, Tenn.).
"Compositions and methods for treating granulomatosis with polyangiitis" was invented by Adam Haeberle (Moorpark, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present specification disclose methods and uses for the treatment of a vasculitic syndrome. The disclosed methods comprise administering a composition comprising a Proteinase 3 (PR3) inhibitor to a patient in need thereof. Also disclosed are compositions comprising a PR3 inhibitor disclosed herein for use in the treatment of a vasculitic syndrome as well as use of a composition comprising a PR3 inhibitor...